货号:GS40603
Retlirafusp is a bispecific antibody designed to simultaneously target PD-L1 and 4-1BB (CD137). It blocks the PD-1/PD-L1 immune checkpoint while conditionally activating 4-1BB on T cells within the tumor microenvironment, aiming to enhance anti-tumor immune responses with reduced systemic toxicity.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
周璐